133 related articles for article (PubMed ID: 37824400)
1. Luteal phase stimulation in double ovarian stimulation cycles is not affected by the follicle-stimulating hormone (FSH) receptor genotype: double ovarian stimulation is beneficial independently of the genotype at position 680 of the follicle-stimulating hormone receptor.
Hortal M; Lledo B; Ortiz JA; Fuentes A; García-Ajofrín C; Romero R; Cascales A; Bernabeu A; Bernabeu R
Pharmacogenet Genomics; 2024 Jan; 34(1):1-7. PubMed ID: 37824400
[TBL] [Abstract][Full Text] [Related]
2. The Ala307Thr polymorphism of the follicle-stimulating hormone receptor (FSHR) gene is associated with the dose of recombinant FSH received during IVF/ICSI treatment.
Dieamant F; Petersen CG; Vagnini LD; Petersen B; Ricci J; Nicoletti A; Zamara C; Oliani AH; Oliveira JBA; Franco JG
JBRA Assist Reprod; 2023 Mar; 27(1):78-84. PubMed ID: 36995260
[TBL] [Abstract][Full Text] [Related]
3. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
[TBL] [Abstract][Full Text] [Related]
4. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype.
Lledó B; Dapena P; Ortiz JA; Morales R; Llacer J; Bernabeu R
Pharmacogenet Genomics; 2016 Jun; 26(6):288-93. PubMed ID: 26959715
[TBL] [Abstract][Full Text] [Related]
6. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
[TBL] [Abstract][Full Text] [Related]
7. Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol.
Poulsen LC; Warzecha AK; Bülow NS; Bungum L; Macklon NS; Yding Andersen C; Skouby SO
Hum Reprod; 2022 Jun; 37(7):1557-1571. PubMed ID: 35652260
[TBL] [Abstract][Full Text] [Related]
8. Luteal-phase ovarian stimulation increases the number of mature oocytes in older women with severe diminished ovarian reserve.
Rashtian J; Zhang J
Syst Biol Reprod Med; 2018 Jun; 64(3):216-219. PubMed ID: 29564925
[TBL] [Abstract][Full Text] [Related]
9. Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial.
Bülow NS; Skouby SO; Warzecha AK; Udengaard H; Andersen CY; Holt MD; Grøndahl ML; Nyboe Andersen A; Sopa N; Mikkelsen ALE; Pinborg A; Macklon NS
Hum Reprod; 2022 Jan; 37(2):309-321. PubMed ID: 34792133
[TBL] [Abstract][Full Text] [Related]
10. A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization.
Mohiyiddeen L; Newman WG; Cerra C; McBurney H; Mulugeta B; Roberts SA; Nardo LG
Fertil Steril; 2013 Jan; 99(1):149-155. PubMed ID: 22985950
[TBL] [Abstract][Full Text] [Related]
11. Luteal Phase Ovarian Stimulation May Improve Oocyte Retrieval and Oocyte Quality in Poor Ovarian Responders Undergoing In Vitro Fertilization: Preliminary Results from a Single-Center Prospective Pilot Study.
Lin LT; Vitale SG; Chen SN; Wen ZH; Tsai HW; Chern CU; Tsui KH
Adv Ther; 2018 Jun; 35(6):847-856. PubMed ID: 29869107
[TBL] [Abstract][Full Text] [Related]
12. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
[TBL] [Abstract][Full Text] [Related]
13. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
14. [Effects of time of recombinant luteinized hormone supplementation on pregnancy outcomes of women with advanced reproductive age during follicular-phase long protocol].
Wang L; Wang J; Hu YQ; Liu JY; Diao FY
Zhonghua Fu Chan Ke Za Zhi; 2022 Oct; 57(10):758-766. PubMed ID: 36299179
[No Abstract] [Full Text] [Related]
15. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
Lazaros L; Hatzi E; Xita N; Takenaka A; Sofikitis N; Zikopoulos K; Georgiou I
J Reprod Med; 2013; 58(9-10):395-401. PubMed ID: 24050028
[TBL] [Abstract][Full Text] [Related]
16. The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia.
Polyzos NP; Neves AR; Drakopoulos P; Spits C; Alvaro Mercadal B; Garcia S; Ma PQM; Le LH; Ho MT; Mertens J; Stoop D; Tournaye H; Vuong NL
Hum Reprod; 2021 May; 36(6):1711-1721. PubMed ID: 33889959
[TBL] [Abstract][Full Text] [Related]
17. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
Esmaeilian Y; Hela F; Bildik G; Akin N; İltumur E; Yusufoglu S; Yildiz CS; Keles İ; Vatansever D; Taskiran C; Yakin K; Oktem O
Hum Reprod; 2023 Jan; 38(1):113-124. PubMed ID: 36367834
[TBL] [Abstract][Full Text] [Related]
18. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
[TBL] [Abstract][Full Text] [Related]
19. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
[TBL] [Abstract][Full Text] [Related]
20. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
